2-氨基-2-环己烯-1-酮 | 37942-94-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-氨基-2-环己烯-1-酮
• 中文别名: 3-氨基-2-环己烯酮
• 英文名称: 2-Cyclohexen-1-one,2-amino-(9CI)
• 英文别名: 2-aminocyclohex-2-en-1-one
• CAS: 37942-94-2
• 化学式: C₆H₉NO
• 分子量: 111.14
• InChiKey: MBPQVWGCNCNOQG-UHFFFAOYSA-N

物化性质

• 沸点：
  243.7±30.0 °C(Predicted)
• 密度：
  1.091±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Fused quinonic compounds
  申请人：Centro Atlantico del Medicamento S.A (Ceamed, S.A)

  公开号：EP2690094A1

  公开（公告）日：2014-01-29

  A compound having the formula (I): for use in treating disease; a composition comprising said fused quinonic compound of formula (I) and at least one pharmaceutically acceptable carrier; as well as a method of modulating a Janus Kinase-Signal Transduction and Activators of Transcription (JAK-STAT) pathway. The activation of a JAK-STAT pathway is associated with several disease states such as immunological and inflammatory diseases, hyperproliferative disorders including cancer, and myeloproliferative diseases.

  具有公式(I)的化合物： 用于治疗疾病；包含所述公式(I)的融合醌类化合物和至少一种药物可接受的载体的组合物；以及一种调节Janus激酶-信号转导和转录激活因子(JAK-STAT)通路的方法。JAK-STAT通路的激活与多种疾病状态有关，如免疫性和炎症性疾病、包括癌症在内的过度增殖障碍以及骨髓增殖性疾病。
• [EN] FUSED QUINONIC COMPOUNDS<br/>[FR] COMPOSÉS QUINONIQUES FUSIONNÉS
  申请人：CT ATLANTICO DEL MEDICAMENTO S A CEAMED S A

  公开号：WO2014016314A1

  公开（公告）日：2014-01-30

  A compound having the formula (I), for use in treating a disease; a composition comprising said fused quinonic compound of formula (I) and at least one pharmaceutically acceptable carrier; as well as a method of modulating a Janus Kinase-Signal Transduction and Activators of Transcription (JAK-STAT) pathway. The activation of a JAK and/or STAT pathways are associated with several disease states such as immunological and inflammatory diseases, hyperproliferative disorders including cancer, and myeloproliferative diseases.

  一个具有公式(I)的化合物，用于治疗疾病；一种包含所述公式(I)的融合醌化合物和至少一种药物可接受载体的组合物；以及一种调节Janus激酶-信号转导和转录激活因子(JAK-STAT)通路的方法。JAK和/或STAT通路的激活与多种疾病状态有关，如免疫性和炎症性疾病、包括癌症在内的过度增殖障碍以及骨髓增殖性疾病。
• FLUORESCENT DYES, METHODS AND USES THEREOF
  申请人：Blackwell E. Helen

  公开号：US20070128658A1

  公开（公告）日：2007-06-07

  The present invention provides a method for identifying and characterizing candidate fluorescent molecules. This method involves the generation of spatially addressed arrays of heterocyclic compounds which are candidate fluorescent molecules. The spatially addressed array can be used to identify fluorescent molecules among the candidate molecules. The spatially addressed array can be used to determine the optical characteristics of one more candidate molecules. The invention also provides methods for making such arrays of heterocyclic compounds. In a specific embodiment, synthetic methods are provided for synthesis of triarylpyridines, particularly unsymmetric triarylpyridines. n preferred embodiments, the present invention provides novel heterocyclic fluorescent compounds having deazalumazine, cyanopyridine or pyrimidine cores. Heterocyclic fluorescent compounds of this invention are useful as dyes to label molecules such as nucleic acids, peptides and proteins, and particularly antibodies. In other embodiments, the novel heterocyclic fluorescent compounds are useful as dyes to label cellular compartments and organelles. The novel heterocyclic fluorescent compounds can also be used as sensors or indicators of specific metal ions, chemical warfare agents and pH.

  本发明提供了一种用于识别和表征候选荧光分子的方法。该方法涉及生成空间定位的杂环化合物阵列，这些化合物是候选荧光分子。空间定位的阵列可用于在候选分子中识别荧光分子。空间定位的阵列可用于确定一个或多个候选分子的光学特性。该发明还提供了制备这种杂环化合物阵列的方法。在一个具体实施例中，提供了合成三芳基吡啶的合成方法，特别是非对称的三芳基吡啶。在首选实施例中，本发明提供了具有脱阿拉木青、氰基吡啶或嘧啶核的新型杂环荧光化合物。本发明的这些杂环荧光化合物可用作染料，用于标记核酸、肽和蛋白质，尤其是抗体。在其他实施例中，这些新型杂环荧光化合物可用作染料，用于标记细胞区室和细胞器。这些新型杂环荧光化合物还可用作特定金属离子、化学战剂和pH的传感器或指示剂。
• HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
  申请人：Turner Sean Colm

  公开号：US20120077840A1

  公开（公告）日：2012-03-29

  The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明涉及一种新型杂环化合物，可用于抑制糖原合成酶激酶3（GSK-3），制备这些化合物的方法，含有这些化合物的组合物，以及使用这些化合物进行治疗的方法。
• Aminocyclohexenone, their preparation and use as medicament against oxidative stress
  申请人：ABIOGEN PHARMA S.p.A.

  公开号：EP2371816A1

  公开（公告）日：2011-10-05

  The present invention concerns amino derivatives of cyclohex-2-enone of formula I : and the salts thereof. Said derivatives have proved to be particularly effective as antioxidants in the treatment of cellular oxidative stress, especially at CNS level.

  本发明涉及公式I的环己-2-酮的氨基衍生物及其盐。这些衍生物已被证明在细胞氧化应激治疗中特别有效，尤其在中枢神经系统水平。